Insider Transactions Reported by 14 Insiders of Tonix Pharmaceuticals Holding Corp.

Symbol
TNXP on Nasdaq
Location
Chatham, NJ

Insiders trading volume in the past year

Tonix Pharmaceuticals Holding Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
SETH LEDERMAN Chief Executive Officer, Director $86,307 +$86,200 +80,561% 15 May 2025
Carolyn E. Taylor Director $15,060 +$15,061 21 Aug 2025
James Treco Director $9,000 +$9,000 20 Aug 2025
Daniel Wintner Goodman Director $8,552 25 May 2021
Siobhan Fogarty Chief Technology Officer $0 25 Feb 2025
RICHARD H. BAGGER Director $0 13 May 2025
ADEOYE OLUKOTUN Director $0 13 May 2025
Margaret Smith Bell Director $0 13 May 2025
GREGORY M. SULLIVAN Chief Medical Officer $0 05 Feb 2025
BRADLEY SAENGER Chief Financial Officer $0 05 Feb 2025
JESSICA MORRIS Chief Operating Officer 05 Feb 2025
James Randolph Hunter Jr Director 12 Jun 2025
Richard Newcomb Stillwell Director 13 May 2025
DAVID L. GRANGE Director 13 May 2025

Recent Insider Transactions by Companies or Individuals for Tonix Pharmaceuticals Holding Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.